The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN

Conditions

• Systemic Lupus Erythematosus
• Lupus Nephritis

Interventions

• BIOLOGICAL: Human umbilical cord mesenchymal stem cells
• DRUG: Interleukin-2

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School